Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 4Trastuzumab 2Interleukin-12 Subunit p35 2Drug Therapy 2tipifarnib 1spartalizumab 1seribantumab 1pertuzumab 1motexafin lutetium 1entinostat 1Thalidomide 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Leucovorin 1Itraconazole 1Irinotecan 1Ipilimumab 1Interleukin-12 1Injections, Subcutaneous 1Immunotherapy 1Gemcitabine 1Fluorouracil 1Fentanyl 1Escitalopram 1Erlotinib Hydrochloride 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Escitalopram × Thoracic × Clear all
NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Massachusetts General Hospital

Phase 3 Terminated
24 enrolled 11 charts
GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡